The surfactants
- PMID: 12141520
- DOI: 10.1055/s-2000-13445
The surfactants
Abstract
Surfactants have been routinely used since 1990 for the treatment of respiratory distress syndrome (RDS). The use of surfactant has coincided with a decrease in mortality in infants due to RDS. This review focuses on clinical aspects of surfactant use. New information, particularly effects of ventilatory styles on surfactant function, is presented.
Similar articles
-
Lung surfactants for replacement therapy: biochemical, biophysical, and clinical aspects.Clin Perinatol. 1987 Sep;14(3):433-79. Clin Perinatol. 1987. PMID: 3311535 Review.
-
Surfactant replacement in neonatal and adult respiratory distress syndrome.Eur J Anaesthesiol. 1984 Dec;1(4):335-43. Eur J Anaesthesiol. 1984. PMID: 6549536
-
Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.Clin Pharm. 1989 Aug;8(8):559-76. Clin Pharm. 1989. PMID: 2670398 Review.
-
Repeat surfactant therapy for postsurfactant slump.J Perinatol. 2006 Jul;26(7):414-22. doi: 10.1038/sj.jp.7211533. Epub 2006 May 18. J Perinatol. 2006. PMID: 16724122
-
Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.J Perinat Med. 2009;37(5):561-4. doi: 10.1515/JPM.2009.100. J Perinat Med. 2009. PMID: 19492923
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources